|The Interaction of Helicobacter pylori with the Adherent Mucus Gel Layer Secreted by Polarized HT29-MTX-E12 Cells.|
|Jump to Full Text|
|PMID: 23056622 Owner: NLM Status: In-Data-Review|
|Helicobacter pylori colonises the gastric mucosa of humans. The majority of organisms live in mucus. These organisms are an important reservoir for infection of the underlying epithelium. Cell culture models for H. pylori infection do not normally possess a mucus layer. The interaction of H. pylori with TFF1, a member of the trefoil factor family found in gastric mucin, is mediated by lipopolysaccharide. To test the hypothesis that the interaction of H. pylori with TFF1 promotes mucus colonization we characterised the interaction of H. pylori with a mucus secreting cell line, HT29-MTX-E12. An isogenic mutant of H. pylori with truncated core oligosaccharides was produced and binding to TFF1 and ability to colonise HT29-MTX-E12 cells determined. The adherent mucus layer of HT29-MTX-E12 cells contained the gastric mucin MUC5AC and trefoil factors, TFF1 and TFF3. H. pylori was found within the mucus layer in discrete clusters and in close association with TFF1. It also interacted with the membrane bound mucin MUC1 and replicated when co-cultured with the cells. An isogenic mutant of H. pylori with a truncated LPS core did not interact with TFF1, and colonization of HT29-MTX-E12 cells was reduced compared to the wild-type strain (p<0.05). Preincubation of cells with wild type LPS but not with truncated LPS resulted in reduced colonization by H. pylori. These results demonstrate that the interaction of TFF1 with H. pylori is important for colonization of gastric mucus and the core oligosaccharide of H. pylori LPS is critical for this interaction to occur. HT29-MTX-E12 cells are a useful system with which to study the interaction of bacteria with mucosal surfaces and the effect of such interactions on mediating colonization.|
|Brendan Dolan; Julie Naughton; Nicole Tegtmeyer; Felicity E B May; Marguerite Clyne|
|Type: Journal Article Date: 2012-10-08|
|Title: PloS one Volume: 7 ISSN: 1932-6203 ISO Abbreviation: PLoS ONE Publication Date: 2012|
|Created Date: 2012-10-11 Completed Date: - Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 101285081 Medline TA: PLoS One Country: United States|
|Languages: eng Pagination: e47300 Citation Subset: IM|
|University College Dublin, School of Medicine and Medical Science, Dublin, Ireland ; Conway Institute of Biomolecular and Biomedical Science, Belfield, Dublin, Ireland ; The National Childrens Research Centre, Dublin, Ireland.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Publisher: Public Library of Science, San Francisco, USA
Copyright: 2012 Dolan et al
Received Day: 29 Month: 5 Year: 2012
Accepted Day: 13 Month: 9 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 8 Month: 10 Year: 2012
Volume: 7 Issue: 10
E-location ID: e47300
PubMed Id: 23056622
Publisher Id: PONE-D-12-15633
|The Interaction of Helicobacter pylori with the Adherent Mucus Gel Layer Secreted by Polarized HT29-MTX-E12 Cells Alternate Title:H. pylori Colonization of Mucus|
|Felicity E. B. May5|
1University College Dublin, School of Medicine and Medical Science, Dublin, Ireland
2School of Biomolecular and Biomedical Science, Dublin, Ireland
3Conway Institute of Biomolecular and Biomedical Science, Belfield, Dublin, Ireland
4The National Childrens Research Centre, Dublin, Ireland
5Faculty of Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
|University of Hyderabad, India
|Correspondence: * E-mail: firstname.lastname@example.org
[conflict] Competing Interests: The authors have declared that no competing interests exist.
Contributed by footnote: Conceived and designed the experiments: MC FEBM BD. Performed the experiments: BD JN NT. Analyzed the data: MC BD FEBM. Contributed reagents/materials/analysis tools: MC FEBM. Wrote the paper: MC BD FEBM.
The majority of bacterial infections in humans and animals result from pathogens colonizing the body via mucosal surfaces such as the gastrointestinal, respiratory and urinary tracts. Helicobacter pylori colonizes the gastric mucosa of humans and primates. Infection occurs early in life  and usually lasts for several decades unless eradicated by antimicrobials. H. pylori has been described as a paradigm for chronic infection of mucosal surfaces . The majority of infecting bacteria live in the mucus layer that overlies the gastric epithelial cells  and colonization of experimental animals suggests that the organisms live close to the epithelial surface . Organisms living in mucus act as a reservoir of bacteria which can interact with the underlying epithelium and consequently cause disease. Elucidation of the mechanisms that H. pylori uses to colonise mucosal surfaces could give us valuable insight into how pathogens overcome the barriers to infection such as the presence of a mucus layer.
H. pylori exhibits a very distinct tropism for the gastric mucin MUC5AC . TFF1, a member of the trefoil factor family of proteins is co-expressed with MUC5AC in the stomach  and also interacts with MUC5AC . TFF1 has been identified as a molecule that interacts with H. pylori. We have previously identified low molecular weight or rough form (RF) lipopolysacharide (LPS) of H. pylori as a bacterial factor that interacts with TFF1 . RF LPS contains the core oligosaccharide region of LPS but lacks the O antigen side chain. The aim of the present study was to test the hypothesis that the interaction of H. pylori with TFF1 promotes colonization of gastric mucus and that the core oligosaccharide of H. pylori LPS is the critical bacterial factor that mediates the interaction between H. pylori and TFF1.
A reliable in vitro system is required to study the role of bacterial colonization of mucus in promoting disease at the molecular and cellular level. Despite the obvious importance of understanding bacterial colonization and infection mechanisms, there are few model systems that allow for comprehensive studies on the role of the adherent mucus layer that covers many mammalian epithelial surfaces. HT29-MTX-E12 cells, a subclone of HT29-MTX cells which have been selected on the basis of tight junction formation, produce a mature adherent mucus gel layer when grown on transwell filters .
We have characterized mucin and trefoil protein expression in HT29-MTX-E12 cells and their adherent mucus layer and infected the cells with H. pylori. We present results which suggest that the interaction of H. pylori with TFF1 in the adherent mucus layer of HT29-MTX-E12 cells is important for colonization. Our results indicate that this cell model system has potential for studying the interaction of bacteria with mucus and the effect of such interactions on mediating bacterial colonization.
The HT29-MTX-E12 cell line, a mucus secreting subclone of the human colorectal adenocarcinoma cell line, HT29-MTX, was a generous gift from Professor Per Artursson, Uppsala University, Sweden. This clone was selected on the basis of tight junction formation and development of a mature adherent mucus layer . HT29-MTX-E12 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM; Lonza) supplemented with 10% (vol/vol) FBS, 1% (vol/vol) non-essential amino acids (Sigma) and 2 mM L-glutamax (Invitrogen). For experiments cells were grown for up to 21 days on Transwell filters 12 mm in diameter, with a 0.4 µm pore size (Millipore). Filters were seeded at a density of 1×105 cells/filter and grown in DMEM F12 which also contained 100 U/ml penicillin (Sigma), 100 µg/ml streptomycin (Sigma) and 125 µg/ml amphotericin B (Sigma). Media was replaced every second day.
The integrity of polarised HT29-MTX-E12 monolayers was checked by measurement of Trans Epithelial Electrical Resistance (TEER) using an EVOMAX meter and STX-2 probe (World Precision Instruments). TEER was measured at different time points over a 21 day culture period and expressed as Ω/cm2.
Transwell filters with either infected or uninfected HT29-MTX-E12 cells were gently washed with sterile PBS, removed from their plastic supports and sandwiched between two thin pieces of chicken liver prior to mounting in Optimal Cutting Temperature (OCT) medium (BDH) as described by Keely etal,. Sections (16 µm thick) of the OCT mounted cultures were cut using a cryostat (Leica) and collected onto polysine coated microscope slides. Sections on slides were allowed to air dry for 10–15 min and were then used immediately or stored at −20°C until use. Some cells were fixed in Carnoys fixative  and paraffin embedded. Sections were cut using a microtome and mounted on polysine slides. PAS staining of frozen sections of HT29-MTX-E12 cells was performed using the Haematoxylin/Periodic Acid Schiff Staining System (Sigma). Staining protocol was based on the manufacturer's guidelines for paraffin embedded tissue sections. Sections were covered with periodic acid solution for 5 min. Slides were washed in several changes of distilled water. Sections were covered with Schiff's reagent for 15 min and then washed under running tap water for 5 min. Finally sections were counterstained with Gill's hematoxylin solution for 90 sec and washed under running tap water. Excess water was removed from the stained slides and coverslips were mounted in DPX (BDH).
Frozen sections of cells were fixed on slides with 2% formalin for 10 min and permeablised with 0.2% (wt/vol) saponin (Sigma) in PBS for 10 min. Sections were incubated for 1 h in 1% (wt/vol) Bovine Serum Albumin (BSA; Sigma) and 10% (vol/vol) serum in PBS. Sections were then incubated overnight with antibodies against TFF1 , TFF2 , TFF3 , MUC1 (Ma522, Novocastra), MUC2 (Ccp58, Novocastra) MUC5AC C-terminus (45M1, Sigma), MUC5AC tandem repeat (CLH2, Santa Cruz), or H. pylori (Dako) at 4°C in a humidified atmosphere, washed with PBS and subsequently incubated with an anti-mouse or anti goat antibody conjugated to Alexafluor 488 (Invitrogen), or an anti rabbit antibody conjugated to either Alexafluor 594 or texas red. The secondary antibody solution included DAPI (Invitrogen) to counterstain the nuclei. Coverslips were mounted on the slides using Fluorescent Mounting Medium (Dako) and the sections were examined with a fluorescent microscope. In order to stain cells for the tight junction protein, ZO-1, the mucus layer was removed from the cells by treatment with N-acetyl cysteine as described previously . After removal of the mucus, cells were fixed and permeabilised in cold methanol (−20°C) for 30 min prior to staining with anti ZO-1 N-terminus (Santa Cruz). Some cells were double labelled with the H. pylori antibody and another antibody (MUC5AC or TFF1 antibody). These samples were permeabilised as described above and incubated first with the H. pylori polyclonal antibody and secondary anti rabbit antibody and subsequently with the desired second primary antibody and secondary anti mouse antibody. Images were acquired with a Zeiss 510 UVMETA Confocal Microscope. Paraffin-embedded samples were deparaffinated and stained with antibodies against the trefoil proteins as described above following heat induced antigen retrieval. Slides were held in a pressure cooker for 3 min in antigen retrieval buffer, 10 mM sodium citrate buffer, pH6.0, containing 0.05% (vol/vol) Tween 20.
Total RNA was extracted from infected and uninfected cells with RNA Trizol reagent (Invitrogen) and was treated with amplification grade DNaseI (Invitrogen). Isolated RNA was quantified using a NanoDrop spectrophotometer. cDNA was synthesised from an equal amount of RNA (2 ug per reaction) using the Superscript First-Strand Synthesis System for RT-PCR (Invitrogen). Synthesised cDNA from 7, 14 and 21 day old uninfected and infected HT29-MTX-E12 cells was probed with primers specific for TFF1, TFF2, TFF3, MUC2, MUC5AC, MUC6 and β actin (Table 1). Primers and conditions used for the detection of trefoil peptide cDNA's were as described previously . Primers and conditions used for the detection of MUC5AC and MUC6 cDNA's were as described by Paulsen etal. Primers for the detection of MUC2 were a kind gift from Dr. Colm Reid (UCD School of Veterinary Medicine). The reaction mixture for MUC2 PCR's consisted of 30.1 µl water, 5 µl 10x reaction buffer (Invitrogen), 1.5 µl 50 mM MgCl2 (final concentration 1.5 mM; Invitrogen), 2 µl 10 mM dNTP mix (final concentration 0.4 mM; Invitrogen), 10 µl forward primer (final concentration 10 pmol), 5 µl reverse primer (final concentration 10 pmol), 0.4 µl Platinum Taq polymerase (2 units; Invitrogen) and 1 µl cDNA. The PCR cycle consisted of an initial incubation at 94°C for 5 min followed by 35 cycles of 94°C for 1 min, 54°C for 1 min and 72°C for 90 sec. The cycle concluded with a final incubation of 72°C for 10 min. The detection of cDNA corresponding to the β actin mRNA was used as a positive control for each PCR. Each reaction contained 30.1 µl autoclaved deionised water, 5 µl 10x PCR buffer (Invitrogen), 1.5 µl 50 mM MgCl2 (final concentration 1.5 mM; Invitrogen), 2 µl 10 mM dNTP mix (final concentration 0.4 mM; Invitrogen), 5 µl forward primer (10 pmol; MWG-Biotech), 5 µl reverse primer (10 pmol; MWG-Biotech), 0.4 µl Platinum Taq polymerase (2 units; Invitrogen) and 1 µl cDNA. The PCR cycle consisted of 94°C for 7 min followed by 35 cycles of 94°C for 30 sec, 55°C for 30 sec and 72°C for 1 min. The cycle concluded with a final extension time of 7 min. All PCR reactions were carried out in 200 µl nuclease free reaction tubes (Sarstedt) in a MWG-Biotech Primus 96 thermocycler. After amplification PCR products were examined by agarose gel electrophoresis. Quantification of RT PCR products was assessed by densitometry using the GelDoc-IT Imaging System and Labworks Analysis software (UVP, Cambridge, UK). Results are an average of three densitometry readings relative to expression of the house keeping gene, β actin.
H. pylori strains PU4, P12 and PA4 were used in this study. Frozen H. pylori stocks were recovered onto Columbia agar (Oxoid) containing 7% (vol/vol) defibrinated horse blood. H. pylori isogenic mutant strains were recovered onto media supplemented with kanamycin sulphate (Fluka) to a final concentration of 10 µg/ml. H. pylori strains were cultured at 37°C in gas jars (Oxoid; BBL) under microaerophillic conditions generated by CampyGen gas packs (Oxoid).
Isogenic mutants PA4ΔHP1191 and P12ΔHP1191 were constructed by insertion of a kanamycin resistance gene cassette (AphA3, 1.4 kb SmaI fragment) in the cloned HP1191 gene according to a standard protocol . Briefly, the gene was amplified by polymerase chain reaction (PCR) using primers 577F 5′ATGAGCGTAAATGCACCCAAACGC and 577R 5′CTCTTCTAAAAGAGTGTGAGCGGC (1,047 bp). The PCR product was cloned in the pGEM-T vector (Promega). After mutagenesis by insertion of the AphA-3 cassette in the genes, 5 µg of supercoiled plasmid DNA was added to 1×108 bacteria per ml in brain heart infusion (BHI) medium. After incubation for 6 h, bacteria were grown on agar plates containing 8 µg per ml kanamycin to select for kanamycin-resistant transformants obtained after 4–5 days of incubation. Correct integration of the AphA-3 cassette into the H. pylori chromosome by double cross-over recombination was confirmed by PCR.
Cells were grown on transwell filters as described above and 24 h before infection antibiotic containing media was removed from the cells, monolayers were gently rinsed with antibiotic free media and cells were incubated in antibiotic free media overnight. Bacteria were grown as described above and used to infect HT29-MTX-E12 cells. H. pylori were harvested from Columbia blood agar into BHI broth at pH 5.0. Media in the lower chamber of the Transwell was replaced with 1.5 ml of sterile antibiotic free DMEM supplemented with 10% (vol/vol) FBS. Since H. pylori cannot survive in DMEM media in the upper chamber of the Transwell was replaced with 100 µl of sterile BHI broth, pH 5.0. These conditions have been shown previously to be able to support H. pylori growth and adherence to polarized epithelial cells without any adverse affects on the epithelial cells . 50 µl of H. pylori suspension, OD600 = 0.4 was then added to the upper chamber of the Transwell. Infected cell cultures were incubated at 37°C in gas jars under microaerophillic conditions generated by CampyGen gas packs for up to 24 h. Bacterial colonization of the cells with H. pylori was assessed by microscopy as described above or by determination of the number of CFU associated with the cells. Infected cultures were gently washed with sterile PBS on both sides of the Transwell. Cells were harvested using trypsin EDTA as described previously . Serial dilutions of the trypsinised cells were plated out in triplicate onto Columbia blood agar plates and incubated at 37°C in gas jars under microaerophillic conditions. Colonies were enumerated after 4–5 days incubation. For blocking experiments with LPS, purified LPS at a concentration of 100 µg/ml from either H. pylori strain PA4 or strain PA4Δ1191 was added to the apical surface of cells growing on Transwell filters for 4 h. Cells with and without LPS were infected with strain PA4 as described above and the number of CFU associated with the cells after a 2 hour incubation period was determined.
LPS was extracted from H. pylori using a mini phenol-water extraction procedure as described by Prendergast etal.
Bacteria were harvested from blood agar plates and resuspended in PBS. The bacterial suspension was then heated to 100°C for 10 min in NuPAGE LDS sample buffer (4X) (Invitrogen).
Lysates of HT29-MTX-E12 cells grown for 21 days on Transwell filters were prepared using a commercially available mammalian cell lysis extraction reagent (CelLytic™ M, Sigma) according to the manufacturers instructions.
Samples of bacterial whole cell lysates, and purified LPS were electrophoresed on NuPAGE® Novex Bis-Tris gels containing 12% acrylamide (Invitrogen). Proteins were transferred to PVDF membrane (Millipore) overnight at 75 mA, 4°C in a wet blotter (BioRad). PVDF membranes were blocked with Marvel (3% wt/vol) in PBS Tween (0.05% vol/vol) for 1 h and then biotinylated TFF1 dimer (5 µg/ml) was added in blocking buffer overnight at 4°C. Blots were washed 3×10 min in PBS Tween (0.05%vvol/vol). Streptavidin-peroxidase was used to detect reactive bands by enhanced chemiluminescence (GE). For detection of the interaction of TFF1 expressed in HT29-MTX-E12 cells with H. pylori LPS blots were overlaid with a whole cell lysate of HT29-MTX-E12 cells for 2 h at 37°C. After washing the filter was incubated with a monoclonal TFF1 antibody followed by horseradish peroxidase-conjugated rabbit anti-mouse antibody. Reactive bands were detected by enhanced chemiluminescence.
Experiments were conducted on at least three separate occasions in triplicates. Results are presented as the means ± standard deviations (error bars) of replicate experiments. Graphs were drawn using either Microsoft Excel or Prism Graph Pad. The Student t test was used to estimate statistical significance. A P value of <0.05 was considered significant.
In order to assess the suitability of HT29-MTX-E12 cells for infection studies with H. pylori and specifically to study the interaction of the organism with trefoil peptides in mucus we characterized tight junction formation and mucin and trefoil peptide expression in the cells.
HT29-MTX-E12 cells were grown for 21 days on Transwell filters. The formation of tight junctions at different time points was measured by monitoring the transepithelial electrical resistance (TEER). As reported previously for HT29-MTX-E12 cells  the TEER increased steadily over time and reached a stable value of approximately 600 Ω/cm2 by days 19–21 (Figure 1A). The location of the tight junction associated protein ZO-1 around the cell membranes confirmed the presence of tight junctions between neighbouring cells (Figure 1B).
Expression of the gastric mucins MUC5AC and MUC6, the intestinal mucin MUC2 and the trefoil proteins TFF1, TFF2 and TFF3 in HT29-MTX-E12 cells was assessed by reverse transcription PCR. MUC5AC mRNA expression was detected readily in HT29-MTX-E12 cells at days 7, 14 and 21. MUC2 mRNA was also present. No expression of MUC6 mRNA was detected at any time during the 21 day culture period (Figure 2A and 2D). TFF1, TFF2 and TFF3 mRNA expression was detected at all times during culture (Figure 2B and 2E). There were no obvious differences in expression of the mRNAs during differentiation of the HT29-MTX-E12 cell monolayer.
The cellular location of the expressed mucin and trefoil proteins was investigated in HT29-MTX-E12 cells grown for 21 days by immunofluoresence with specific antibodies against MUC1, MUC2, MUC5AC, TFF1, TFF2 and TFF3. The membrane bound mucin MUC1 was localised on the apical surface of the cells. MUC2 was detected intracellularly in occasional cells. There was clear apical, intracellular expression of MUC5AC, TFF1, TFF2 and TFF3 (Figure 3). Particularly strong expression of TFF1 was detected in the mucus vesicles on the surface of the HT29-MTX-E12 cells.
The adherent mucus layer of HT29-MTX-E12 cells is largely destroyed during formalin fixation and paraffin embedding. To preserve the mucus layer, polarised HT29-MTX-E12 cells grown on transwell filters for 21 days were wrapped in liver, embedded in OCT and frozen in liquid nitrogen. Frozen cells were sectioned using a cryostat and stained with PAS and haematoxylin or with specific antibodies. Incubation of frozen sections with PAS and haematoxylin demonstrated that the cells had formed a thick adherent mucus gel layer. The presence of the mucin MUC5AC and the trefoil proteins TFF1 and TFF3 in the adherent mucus layer were confirmed by immunofluoresence with specific antibodies (Figure 4). MUC2 and TFF2 were not detected in the adherent mucus layer by immunofluorescent microscopy. This result was not surprising for MUC2 as we only detected occasional cells expressing this mucin intracellularly. There was however good intracellular expression of TFF2. The reason why we did not detect extracellular TFF2 however may be due either to lack of secretion of this protein from the cells or possibly the antibody may require heat induced antigen retrieval of the cells to work.
All our infection studies were with HT29-MTX-E12 cells after 21 days of culture because at this time they had formed tight junctions and secreted a mature adherent mucus layer which contained the mucin MUC5AC and trefoil protein TFF1. Cells were infected with H. pylori for up to 24 h. Single H. pylori organisms could be visualised clearly by immunofluorescent confocal microscopy in frozen sections of HT29-MTX-E12 cells. The bacteria were found in discrete foci or clusters within the MUC5AC mucus layer (Figure 5a). Bacteria were also found at the apical surface of the underlying epithelial cells interacting with the membrane bound mucin MUC1 (Figure 5B). The infected cells were lysed and the number of CFU of bacteria recovered after different times of infection was measured. This quantifies the total number of bacteria in the adherent mucus layer and associated directly with the cells. Two hours post infection, 4.12×105 CFU/ml were recovered and by 24 h this had increased 16-fold to 6.5x106 CFU/ml, (p≤0.05), (Figure 5C). The ability of H. pylori to replicate when co-cultured with HT29-MTX-E12 cells was assessed by washing cells to remove any non colonizing bacteria 2 h after infection, replacing the medium and then measuring the number of CFU/ml present in cell lysates at different time points. Two hours after infection, 3.53×105 CFU/ml were associated with HT29-MTX-E12 cells. By 22 h after removal of the bacteria that had not colonised the HT29-MTX-E12 cells, the number of bacteria had increased nearly 25-fold to 8.17×106 CFU/ml (p≤0.05) (Figure 5D). This increase in bacterial load in the adherent mucus and associated with the cells must be due to bacterial replication as there were no bacteria in the medium available for further colonization after the 2 h timepoint. These results demonstrate that H. pylori colonizes HT29-MTX-E12 cells and that the bacteria undergo cell division with a cell doubling time of approximately 4–5 h.
As described above, we showed that the extracellular mucus layer produced by HT29-MTX-E12 cells contains TFF1 and that after infection H. pylori organisms can be visualised within the mucus layer. We investigated if the bacteria might interact with TFF1 in this HT29-MTX-E12 cell model (Figure 6). TFF1 immunofluorescence was discrete and the H. pylori foci co-localised with areas of TFF1 expression in the HT29-MTX-E12 mucus layer which is consistent with there being an interaction between TFF1 and H. pylori in adherent mucus.
We tested if TFF1 or TFF3 produced by HT29-MTX-E12 cells interacts with H. pylori LPS as has been shown previously with recombinant trefoil peptides . Total H. pylori cell lysate or purified LPS were transferred onto PVDF membranes and incubated with HT29-MTX-E12 cell lysate. The membranes were then incubated with specific antibodies against either TFF1 or TFF3 to detect protein that had bound to constituents of H. pylori immobilised on the membranes. Strong binding of TFF1 to the low molecular weight LPS present in whole H. pylori lysate and to purified H. pylori LPS was detected indicating that TFF1 produced by HT29-MTX-E12 cells interacts with H. pylori rough form LPS (Figure 7A and 7B). There was some interaction of TFF3 with purified LPS of H. pylori but the interaction with the cell lysate was barely detectable (Figure 7C). These results suggest that H. pylori can interact with TFF1 in HT29-MTX-E12 cells and that there is also some interaction, albeit not as strong as the interaction with TFF1, with TFF3 and that the interaction of H. pylori with TFF1 and TFF3 in HT29-MTX-E12 cells is mediated probably by H. pylori LPS.
H. pylori isogenic mutants with truncated LPS are unable to interact with TFF1 and exhibit reduced colonization of HT29-MTX-E12 cells.
In order to further test the importance of H. pylori LPS interaction with TFF1 in mediating H. pylori colonization of adherent mucus, we constructed isogenic mutants of H. pylori that produce truncated LPS core oligosaccharides. HP1191, encodes an LD-heptosyltransferase which has been shown to be involved in the biosynthesis of the inner core region of the oligosaccharide portion of LPS of H. pylori strain 26695 and insertional inactivation of HP1191 resulted in the production of LPS with a severely truncated core oligosaccharide . We constructed H. pylori strain PA4ΔHP1191 and tested the ability of TFF1 to bind to the LPS of PA4 wild-type and PA4ΔHP1191. Alcian blue staining of LPS on SDS PAGE gels and western blotting with antibodies against Lewis x demonstrated that compared to LPS from the wild type parental strain PA4, the LPS of PA4ΔHP1191 was truncated and no longer expressed O antigen side chain as evidenced by lack of reactivity with antibodies against Lewis x (Figure 8A). Dimeric TFF1 bound to LPS from PA4 but not to LPS from PA4ΔHP1191 (Figure 8A) which indicates that it is the core oligosaccharide portion of H. pylori LPS that interacts with TFF1. We then assessed colonization of HT29-MTX-E12 cells by wild type strains PA4 and P12 and mutants PA4ΔHP1191 and P12ΔHP1191. The level of colonization by both mutants was significantly reduced compared to colonization by the wild-type parental strains (p<0.05) (Figure 8B). Incubation of cells with LPS from wild type strain PA4 but not with LPS from strain PA4ΔHP1191 and subsequent colonization of cells with strain PA4 resulted in reduced bacterial colonization compared to cells infected in the absence of LPS (p<0.05) (Figure 8C).
To date the in vitro cell culture models used to study the interaction of bacteria with epithelial surfaces have been confined largely to epithelial cell lines which do not produce an adherent mucus gel layer. This has limited our understanding of the interactions between bacteria and mucus which are an important first step in colonisation. In order to assess the role of TFF1 in mediating H. pylori colonization of adherent mucus we had to identify a suitable in vitro model system. HT29-MTX-E12 cells grew in a similar way to that described previously . During the 21 days in culture, the TEER increased which is indicative of tight junction formation and cell polarization. It has been shown that this cell line differentiates into mature mucus secretory cells . PAS-Schiff staining confirmed that after 21 days of culture, HT29-MTX-E12 cells had formed an adherent mucus layer.
H. pylori was able to colonize HT29-MTX-E12 cells and bacteria could be visualized in the mucus layers of infected cells and close to the epithelial surface of the cells. H. pylori could be visualised within the mucus layer usually occurring in discrete clusters throughout the mucus and the organism was able to reproduce when co-cultured with the cells. H. pylori has also been shown to reproduce and form microcolonies over the intercellular junctions at the apical surface of polarized MDCK cells . In addition a recent study has reported that the interaction of H. pylori with oligosaccharides present on mucins can promote bacterial proliferation . The closely related organism Campylobacter jejuni can also colonize and reproduce when co-cultured with HT29-MTX-E12 cells. C. jejuni was scattered throughout the mucus layer, inside the cells, between the cells and at the basolateral surface . This was in stark contrast to H. pylori, where the organisms were found in discrete foci within the mucus layer. This suggests that HT29-MTX-E12 cells may be a useful model to discriminate between different patterns of infection that occur with various pathogens.
The predominant secreted mucin detected in the mucus layer was MUC5AC with only very small amounts of MUC2 produced at any time point. MUC5AC, which is produced in vivo in the stomach, was localized to both the mucus layer and mucin granules whereas the intestinal mucin, MUC2 was only detected intracellularly in a small number of cells. There was prominent immuno-reaction with the membrane bound mucin MUC1 which is exposed on the apical surface of cells embedded in the plasma membrane and does not form a mucus gel. H. pylori binds directly to purified MUC5AC and MUC1 mucins ,  and MUC1 has been shown to be important in limiting infection by Helicobacter and Campylobacter in a mouse model of infection , . In this study H. pylori interacted directly with MUC1 on the apical surface of the cells. Interestingly recent work has shown that over expression of MUC1 counter regulated H. pylori induced gastric inflammation . A follow on study has demonstrated that the interaction of H. pylori with MUC1 blocks H. pylori stimulated β-catenin nuclear translocation and attenuates IL-8 production and neutrophil gastric inflammation . The speculation by the authors that augmented expression of MUC1 could be used for treatment of H. pylori gastritis highlights the need for model systems that express adherent mucus layers and appropriate mucins in order to test such hypotheses. The expression of MUC5AC and MUC1 by HT29-MTX-E12 cells suggest that these cells may be a useful system to further elucidate how H. pylori interacts with these mucins and the importance of the interactions for the development of disease and/or host defence.
Trefoil proteins are an integral structural component of mucus gels and TFF1 has been shown to be concentrated in the normal human gastric adherent mucus gel layer . RT-PCR confirmed mRNA expression of all three trefoil factor family members in HT29-MTX-E12 cells. TFF1, TFF2 and TFF3 proteins were detected intracellularly concentrated in the mucus granules of the differentiated HT29-MTX-E12 cells and staining of TFF1 and TFF3 was evident in the adherent mucus gel layer. We could not detect TFF2 expression in the adherent mucus gel layer by immunostaining but as previously mentioned we think this may be due to the fact that our antibody may not work with frozen sections. Although HT29-MTX-E12 cells are a colonic cell line they do have a gastric phenotype. The predominant mucin expressed and secreted is MUC5AC and they also express the gastric trefoil proteins TFF1 and TFF2. These findings suggested to us that these cells were likely to be suitable to assess the importance of the interaction of H. pylori with trefoil peptides in mediating colonization of mucus.
H. pylori was found in close association with TFF1 in HT29-MTX-E12 cells. In addition overlay blotting studies showed that TFF1 produced by E12 cells could interact with H. pylori LPS. Previous work with gastric tissue sections has indicated that the interaction of TFF1 with LPS plays an important role in mediating H. pylori colonization of the gastric mucosa . To elucidate further the biological relevance of the H. pylori LPS interaction with TFF1, we constructed isogenic mutants of H. pylori that produce truncated forms of the core oligosaccharide of H. pylori LPS. Low molecular weight LPS of H. pylori has been shown to mediate binding of H. pylori to TFF1 . H. pylori PA4ΔHP1191 was unable to bind to TFF1 and exhibited reduced colonization of HT29-MTX-E12 cells compared to the wild type strain. Reduced colonization was also demonstrated with P12ΔHP1191. In a study from another laboratory a Hp1191 mutant created in H. pylori strain 26695 was able to invade AGS cells to a comparable level compared to the wild type strain . This indicates that the decrease in colonization of HT29-MTX-E12 cells by PA4ΔHP1191 and P12ΔHP1191 is most likely due to lack of ability to interact with TFF1 in the mucus layer rather than an inability to interact with epithelial surfaces. The presence of LPS from wild type bacteria but not truncated LPS from PA4ΔHP1191 reduced colonization by wild type bacteria. Together these results demonstrate the likely importance of the interaction of TFF1 with H. pylori in the gastric mucosa and the role of the core oligosaccharide of H. pylori LPS in mediating that interaction.
In summary these results suggest that HT29-MTX-E12 cells are a useful model for the study of how mucosal pathogens interact with mucus gels. The finding that TFF1 may be important in mediating H. pylori colonization of the gastric mucosa suggests that we need to consider carefully the role of non mucin components of mucus in mediating infection of mucosal surfaces. TFF1 is present in the gastric mucosa bound covalently to a protein known as TFIZ1 or gastrokine 2 . In addition, it has been shown that TFF1 interacts directly with MUC5AC in vivo. We do not know if the interaction of H. pylori with TFF1 has an influence on TFF1 binding to other molecules and if it does what the biological consequences are. Studies now need to address these possibilities.
We would like to thank Professor Per Artursson, Uppsala University for providing the HT29- MTX-E12 cells.
|1.||Rowland M,, Daly L,, Vaughan M,, Higgins A,, Bourke B,, et al. (Year: 2006) Age-specific incidence of Helicobacter pylori. Gastroenterology130: 65–7216401469|
|2.||Israel DA,, Peek RM Jr, (Year: 2006) The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol22: 3–716319669|
|3.||Hessey SJ,, Spencer J,, Wyatt JI,, Sobala G,, Rathbone BJ,, et al. (Year: 1990) Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut31: 134–1382311970|
|4.||Schreiber S,, Konradt M,, Groll C,, Scheid P,, Hanauer G,, et al. (Year: 2004) The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci U S A101: 5024–502915044704|
|5.||Van den Brink GR,, Tytgat KM,, Van der Hulst RW,, Van der Loos CM,, Einerhand AW,, et al. (Year: 2000) H pylori colocalises with MUC5AC in the human stomach. Gut46: 601–60710764701|
|6.||Longman RJ,, Douthwaite J,, Sylvester PA,, Poulsom R,, Corfield AP,, et al. (Year: 2000) Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut47: 792–80011076877|
|7.||Ruchaud-Sparagano MH,, Westley BR,, May FE, (Year: 2004) The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa. Cell Mol Life Sci61: 1946–195415289936|
|8.||Clyne M,, Dillon P,, Daly S,, O'Kennedy R,, May FE,, et al. (Year: 2004) Helicobacter pylori interacts with the human single-domain trefoil protein TFF1. Proc Natl Acad Sci U S A101: 7409–741415123808|
|9.||Reeves EP,, Ali T,, Leonard P,, Hearty S,, O'Kennedy R,, et al. (Year: 2008) Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner. Gastroenterology135: 2043–205418848942|
|10.||Behrens I,, Stenberg P,, Artursson P,, Kissel T, (Year: 2001) Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm Res18: 1138–114511587485|
|11.||Keely S,, Rawlinson LA,, Haddleton DM,, Brayden DJ, (Year: 2008) A tertiary amino-containing polymethacrylate polymer protects mucus-covered intestinal epithelial monolayers against pathogenic challenge. Pharm Res25: 1193–120118046631|
|12.||Ishihara S,, Okuyama T,, Ishimura N,, Ono M,, Hashimoto T,, et al. (Year: 2001) Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: study using Carnoy's fixation and immunohistochemistry for detection of bacteria. Aliment Pharmacol Ther15: 1485–149111552923|
|13.||Westley BR,, Griffin SM,, May FE, (Year: 2005) Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. Biochemistry44: 7967–797515924415|
|14.||May FE,, Semple JI,, Prest SJ,, Westley BR, (Year: 2004) Expression and motogenic activity of TFF2 in human breast cancer cells. Peptides25: 865–87215177883|
|15.||Lafontaine PO,, Arnal M,, Buron N,, Solary E,, Bron AM,, et al. (Year: 2005) Trefoil factor family mRNA and protein expression in pterygium. Int J Oncol27: 997–100316142316|
|16.||Alemka A,, Clyne M,, Shanahan F,, Tompkins T,, Corcionivoschi N,, et al. (Year: 2010) Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Infect Immun78: 2812–282220308300|
|17.||Wiede A,, Hinz M,, Canzler E,, Franke K,, Quednow C,, et al. (Year: 2001) Synthesis and localization of the mucin-associated TFF-peptides in the human uterus. Cell Tissue Res303: 109–11511235998|
|18.||Paulsen FP,, Corfield AP,, Hinz M,, Hoffmann W,, Schaudig U,, et al. (Year: 2003) Characterization of mucins in human lacrimal sac and nasolacrimal duct. Invest Ophthalmol Vis Sci44: 1807–181312714609|
|19.||Backert S,, Ziska E,, Brinkmann V,, Zimny-Arndt U,, Fauconnier A,, et al. (Year: 2000) Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol2: 155–16411207572|
|20.||Cottet S,, Corthesy-Theulaz I,, Spertini F,, Corthesy B, (Year: 2002) Microaerophilic conditions permit to mimic in vitro events occurring during in vivo Helicobacter pylori infection and to identify Rho/Ras-associated proteins in cellular signaling. J Biol Chem277: 33978–3398612058029|
|21.||Prendergast MM,, Kosunen TU,, Moran AP, (Year: 2001) Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains. J Clin Microbiol39: 1494–150011283076|
|22.||Chandan V,, Logan SM,, Harrison BA,, Vinogradov E,, Aubry A,, et al. (Year: 2007) Characterization of a waaF mutant of Helicobacter pylori strain 26695 provides evidence that an extended lipopolysaccharide structure has a limited role in the invasion of gastric cancer cells. Biochem Cell Biol85: 582–59017901900|
|23.||Tan S,, Tompkins LS,, Amieva MR, (Year: 2009) Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog5: e100040719412339|
|24.||Skoog EC,, Sjoling A,, Navabi N,, Holgersson J,, Lundin SB,, et al. (Year: 2012) Human Gastric Mucins Differently Regulate Helicobacter pylori Proliferation, Gene Expression and Interactions with Host Cells. PLoS One7: e3637822563496|
|25.||Linden S,, Nordman H,, Hedenbro J,, Hurtig M,, Boren T,, et al. (Year: 2002) Strain- and blood group-dependent binding of Helicobacter pylori to human gastric MUC5AC glycoforms. Gastroenterology123: 1923–193012454849|
|26.||Linden SK,, Sheng YH,, Every AL,, Miles KM,, Skoog EC,, et al. (Year: 2009) MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog5: e100061719816567|
|27.||McAuley JL,, Linden SK,, Png CW,, King RM,, Pennington HL,, et al. (Year: 2007) MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest117: 2313–232417641781|
|28.||McGuckin MA,, Every AL,, Skene CD,, Linden SK,, Chionh YT,, et al. (Year: 2007) Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology133: 1210–121817919495|
|29.||Guang W,, Ding H,, Czinn SJ,, Kim KC,, Blanchard TG,, et al. (Year: 2010) Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J Biol Chem285: 20547–2055720430889|
|30.||Guang W,, Twaddell WS,, Lillehoj EP, (Year: 2012) Molecular Interactions between MUC1 Epithelial Mucin, beta-Catenin, and CagA Proteins. Front Immunol3: 10522566976|
|31.||Newton JL,, Allen A,, Westley BR,, May FE, (Year: 2000) The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut46: 312–32010673290|
|32.||Lichtenberger C,, Zakeri S,, Baier K,, Willheim M,, Holub M,, et al. (Year: 1999) A novel high-purity isolation method for human peripheral blood neutrophils permitting polymerase chain reaction-based mRNA studies. J Immunol Methods227: 75–8410485256|
Table 1 Oligonucleotide primers used for reverse transcriptase PCR.
|Forward Primer||Reverse Primer||Reference|
|TFF1||[gene: TTTGGAGCAGAGAGGAGG]||[gene: TTGAGTAGTCAAAGTCAGAGCAG]|||
|TFF2||[gene: AGTGAGAAACCCTCCCCC]||[gene: AACACCCGGTGAGCCAG]|||
|TFF3||[gene: GTGCCAGCCAAGGACAG]||[gene: CGTTAAGACATCAGGCTCCAG]|||
|MUC2||[gene: CACCCCTTCCTCAACTACCA]||[gene: CGGAGTTGGGTTCTCTGTG]||This study|
|MUC6||[gene: CAGCAGGAGGAGATCACGTTCAAG]||[gene: GTGGGTGTTTTCCTGTCTGTCATC]|||
|β Actin||[gene: GCTATCCCTGTACGCCTCTG]||[gene: CTCCTTCTGCATCCTGTCGG]|||
Previous Document: Ontogeny of adaptive antibody response to a model antigen in captive altricial zebra finches.
Next Document: The first mitochondrial genome for the fishfly subfamily chauliodinae and implications for the highe...